company

STAVANGER UROLOGISKE SENTER AS

4020 STAVANGER

Return on Equity
5 103,8 %
Current Ratio
0,94
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue12 768 000
Net Income4 032 000
Total Assets6 307 000
Total Equity79 000
Income (NOK)2022
Revenue12 768 000
Expenditure7 608 000
Operating Profit5 160 000
Financial Income14 000
Financial Costs3 000
Financial Balance11 000
Earnings Before Tax5 171 000
Tax1 139 000
Net Income4 032 000
Balance (NOK)2022
Total Fixed Assets453 000
Total Current Assets5 854 000
Total Assets6 307 000
Total Retained Equity49 000
Total Equity79 000
Total Long-Term Debt0
Total Current Debt6 228 000
Total Equity and Debt6 307 000
Cash flow (NOK)2022
Sales Income12 572 000
Other Income195 000
Revenue12 768 000
Cost of Goods Sold1 464 000
Salary Costs4 794 000
Depreciation115 000
Impairment0
Expenditure7 608 000
Operating Profit5 160 000
Financial Income14 000
Financial Costs3 000
Financial Balance11 000
Dividends4 000 000
Net Income4 032 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets50 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures393 000
Total Tangible Assets393 000
Total Fiancial Fixed Assets10 000
Total Fixed Assets453 000
Stock25 000
Total Investments0
Cash, Bank2 353 000
Total Current Assets5 854 000
Total Assets6 307 000
Total Equity79 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors241 000
Unpaid Taxes470 000
Dividends4 000 000
Other Current Debt387 000
Total Current Debt6 228 000
Total Equity and Debt6 307 000
Financial indicators2022
Return on Equity5 103,8 %
Debt-to-Equity Ratio0
Operating Profit Margin40,41 %
Current Ratio0,94
Quick Ratio0,94
Equity Ratio0,01
Gross Profit Margin88,53 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English